{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-024760","form_type":"8-K","ticker":"AIM","cik":"0000946644","company_name":"AIM ImmunoTech Inc.","filed_at":"2026-05-21T15:31:14+00:00","discovered_at":"2026-05-21T15:32:00.221155+00:00","generated_at":"2026-05-21T15:33:58.587817+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"AIM ImmunoTech prices $2.4M registered direct offering of 7.5M shares and warrants","bullets":["Offering of 7,519,351 shares at $0.325 per share; gross proceeds ~$2.4M before expenses.","Concurrent private placement of Common Warrants to purchase up to 15,038,702 shares at $0.325.","Warrants exercisable after stockholder approval, expire 5 years later; potential additional $4.9M.","Closing expected May 21, 2026; company expects at least $6M in stockholders' equity post-closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-024760","json":"https://secwatch.observer/filing/0001493152-26-024760.json","markdown":"https://secwatch.observer/filing/0001493152-26-024760.md","text":"https://secwatch.observer/filing/0001493152-26-024760.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946644/000149315226024760/0001493152-26-024760-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946644/000149315226024760/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T15:33:58.587817+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6c17d923974073bdfdeae2cd31069c211f78f337","claim":"AIM ImmunoTech Inc. entered into Purchase Agreement with institutional investors valued at approximately $2.4 million (effective 2026-05-20).","evidence_excerpt":"On May 20, 2026, AIM ImmunoTech Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with institutional investors (the “Investors”), pursuant to which the Company agreed to issue and sell to such investors in a registered direct offering 7,519,351 shares (the “Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company, at an offering price of $0.325 per share (such registered direct offering, the “Registered Offering”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/946644/000149315226024760/0001493152-26-024760-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"institutional investors"},{"label":"Value","value":"approximately $2.4 million"},{"label":"Effective","value":"2026-05-20"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}